Today: 19 March 2026
Browse Category

NYSE:UNH 17 August 2025 - 21 October 2025

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Group shares closed at $364.48 on Oct. 21, up 2.2% on the day but still down about 30% for 2025 after plunging from an April peak near $630. The company will report Q3 earnings Oct. 28, with analysts expecting a sharp profit drop after UnitedHealth cut its full-year outlook due to surging medical costs. CEO Andrew Witty resigned in May, replaced by Stephen Hemsley.
21 October 2025
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group closed near $372 on Oct. 8, up over 2%, but remains far below its April high of $630. The company reported $422.8 billion in trailing 12-month revenue and $21.3 billion net income. Analysts raised price targets after recent upgrades, but the stock faces pressure from rising medical costs and regulatory probes. Third-quarter results are due Oct. 28, with guidance cut to $14.65 per share.
8 October 2025
Global Business Weekend: Record Highs, AI Shake-ups, Oil Bears & Major Deals

Global Business Weekend: Record Highs, AI Shake-ups, Oil Bears & Major Deals

The Dow Jones Industrial Average hit a record intraday high, surpassing its December peak, as UnitedHealth shares jumped 9.5% after Berkshire Hathaway disclosed a stake. Nvidia’s market value reached $4 trillion. Apple announced an additional $100 billion investment in U.S. projects. Meta Platforms reorganized its AI teams and secured $29 billion in financing for data centers.
1 7 8 9

Stock Market Today

  • Cameco Stock Seen as a Long-Term Hold Amid Nuclear Energy Shift and Strategic Investments
    March 19, 2026, 5:08 PM EDT. Cameco (TSX:CCO) has delivered a 578% gain over five years, but some investors are choosing to hold the stock indefinitely. The company benefits from a solid backlog of long-term uranium supply contracts, including a recent $2.6 billion deal with India, ensuring stable revenues amid spot price fluctuations. Positioned across the nuclear value chain via Westinghouse and Global Laser Enrichment, Cameco is set to capitalize on the growing nuclear power needs driven by artificial intelligence (AI) and demand for carbon-free energy. The potential Westinghouse IPO and growth at Global Laser Enrichment add further optionality. For retirement-focused investors, selling now might pose greater risk given the company's strategic outlook and industry trends favoring nuclear energy as a baseload power source.
Go toTop